INDIANAPOLIS—When Covid-19 struck, drug companies around the world began racing to find vaccines and treatments. One factor has gummed up their efforts: They have to work in an environment transformed by the very problem they are trying to tackle.

At Eli Lilly & Co., the chief of a laboratory, quarantining at home after he contracted Covid-19, had to use a robot equipped with an iPad to patrol his lab. When shipping constraints threatened to delay testing of an experimental drug, Lilly repurposed its corporate jet to get vials…

This post first appeared on wsj.com

You May Also Like

Israel-Hamas war has now killed at least 30,000 Palestinians, most of them civilians

Around 60% of the residential buildings in Gaza have been damaged and…

Solar-Power Developers Pledge to Buy U.S. Panels—If Someone Makes Them

A group of U.S. renewable-energy developers is making a $6 billion offer…

SoftBank Chief Pulls Back From Brink—With Help

Japanese tech billionaire Masayoshi Son late this spring said he had “peered…

Honda, LG Energy Plan $4.4 Billion EV Battery Factory in U.S.

TOKYO—Honda Motor and LG Energy Solution said Monday they plan to build…